Close
More
 
back_btn_arrow   Go back
Sign up or login to continue
New to QuantiaMD?
QuantiaMD is a free service for United States Healthcare Professionals.
*Please fill in all required fields.
By clicking "Sign up", I agree to the Terms of Use and Privacy Policy. and attest I am a healthcare professional.
Existing QuantiaMD member:
Sign up or login to continue
New to QuantiaMD?
Simply enter a password to join for free, if the information below is correct.
 
*Please enter a valid email address and password.
By clicking "Sign up", I agree to the Terms of Use and Privacy Policy. and attest I am a healthcare professional.
Forgot your password?  Reset now
Existing QuantiaMD member:
Please login to continue
Welcome! Great to have you back.
*Your email address or password is incorrect.
Forgot your password?  Reset now
Reset your password
Please enter your email address, and we will send you a link to reset your password.
*Please enter a valid email address.

is already registered on QuantiaMD

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Forgot your password?  Reset now
Need more help? Contact Member Support

is already registered on QuantiaMD

Instructions to create a new password have been sent to the following email address:

For further assistance, please Contact Member Support
Thanks for Registering.

Create new password?

Please enter your email address below, and we will send you a link to create a new password.

Submit

Create new password?

Email address:
 
Password
 
Confirm password
 
Submit
Earn this Certificate
0%
0 out of 8 completed
Cutting Coronary Artery Disease Risks

Leaders in coronary care share their expert advice on how to reduce CAD risks in your patients. How does lowering risks result in reduced events? What interventions have the greatest impact on cutting morbidity and mortality? Join us to hear how leaders in the field are making treatment decisions in their clinics.

Christopher Cannon, MD, FACC
Cardiovascular Division, Brigham and Women's Hospital, Executive Director of Cardiometabolic Trials, Harvard Clinical Research Institute
Start the next presentation
You've completed 0 out of 8 presentations
 
Expert Practice Series Presentations
Christopher Cannon, MD, FACC
Executive Director, Cardiometabolic Trials, Harvard Clinical Research Institute, Cardiovascular Division, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
(1,094)
505 Comments
Michael Miller, MD
Professor of Medicine, Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Director, Center for Preventive Cardiology, University of Maryland Medical Center
(927)
306 Comments
Benjamin Scirica, MD, MPH, FACC
Director of Quality Initiatives, Cardiovascular Division, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School
(851)
407 Comments
George L. Bakris, MD, FASN, FASH
Professor of Medicine, The University of Chicago Medicine; Director, ASH Comprehensive Hypertension Center, The University of Chicago Medicine
(680)
417 Comments
Christopher Cannon, MD, FACC
Director, Cardiometabolic Trials Harvard Clinical Research Institute, Cardiovascular Division, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
(324)
330 Comments
Amit Khera, MD, MSc, FACC, FAHA
Associate Professor, Director, Preventive Cardiology Program, Program Director, Cardiology Fellowship, UT Southwestern Medical Center
(1,482)
339 Comments
Deepak L. Bhatt, MD, MPH
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center, Professor of Medicine, Harvard Medical School
(819)
289 Comments
Paul M Ridker, MD, MPH, FACC, FAHA
Eugene Braunwald Professor of Medicine, Harvard Medical School, Director, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital
(1,272)
135 Comments
Latest Comments
"Nice presentation!

Do you still want to keep DBP above 60 in hypertensive elderly patients with aortic insuffiency?"
Jeff The, DO
Internist
417 Comments
"Atorvastatin is an equivalent choice and is generic. Both have great evidence backing them!"
Amanda Keys, NP
Nurse Practitioner, Imperial Health Cardiovascular Specialists
135 Comments
 

QuantiaMD + Univadis is a free, time-saving medical news & education community designed exclusively for healthcare professionals. Unique executive summaries from Univadis tame the onslaught of medical literature and keep clinicians up to date in just a few minutes per day. Concise, interactive educational presentations from our experts on QuantiaMD help clinicians stay on top of practice-changing research and trends, and collaborate with colleagues at any time, on any device.

Aptus Health does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Aptus Health sources.

Copyright © 2017 Aptus Health, Inc. All rights reserved. Version 2.13.137.147 

Mobile App

Contact Us

1-800-773-4162
Monday - Friday 8am to 7pm ET

support@quantiamd.com